Clinical Trial Update: A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating a 3- to 5-day course of levamisole in Loa loa (loiasis) infected subjects and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Loiasis

Drugs mentioned

• Levamisole (levamisole)

Snippet

Sponsor: Programme National de Lutte contre l'Onchocercose, Republic of the Congo | Conditions: Loiasis | Phase 2, Phase 3 | Status: RECRUITING